Requirement for cyclin D3 in germinal center formation and function.
Germinal centers (GC) of secondary lymphoid tissues are critical to mounting a high-affinity humoral immune response. B cells within the GC undergo rapid clonal expansion and selection while diversifying their antibody genes. Although it is generally believed that GC B cells employ a unique proliferative program to accommodate these processes, little is known about how the GC-associated cell cycle is orchestrated. The D-type cyclins constitute an important component of the cell cycle engine that enables the cells to respond to physiological changes. Cell type- and developmental stage-specific roles of D-type cyclins have been described but the cyclin D requirement during GC reaction has not been addressed. In this study, we report that cyclin D3 is largely dispensable for proliferation and Ig class switching of in vitro activated B cells. In contrast, GC development in Ccnd3(-/-) mice is markedly impaired, as is the T cell-dependent antibody response. Within the GC, although both switched and unswitched B cells are affected by cyclin D3 inactivation, the IgM(-) pool is more severely reduced. Interestingly, despite a compensatory increase in cyclin D2 expression, a significant number of Ccnd3(-/-) GC B cells accumulate in quiescent G0 state. Lastly, although cyclin D3 inactivation did not disrupt BCL6 expression in GC B cells, it completely blocked the GC promoting effect of BCL6 overexpression, suggesting that cyclin D3 acts downstream of BCL6 to regulate GC formation. This is the first demonstration that cyclin D3 plays an important and unique role at the GC stage of B cell development.
Peled
Jonathan U
JU
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Yu
J Jessica
JJ
Venkatesh
Jeganathan
J
Bi
Enguang
E
Ding
B Belinda
BB
Krupski-Downs
Melissa
M
Shaknovich
Rita
R
Sicinski
Piotr
P
Diamond
Betty
B
Scharff
Matthew D
MD
Ye
B Hilda
BH
D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology; D056743:Cyclin D3 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D018858:Germinal Center / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation / Q000235:genetics / Q000276:immunology; D008221:Lymphoid Tissue / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout
D056743:Cyclin D3
Cancer Cell. 2005 May;7(5):445-55
15894265
Mol Cell Biol. 2005 Dec;25(23):10205-19
16287839
Immunology. 2004 Aug;112(4):509-20
15270721
J Immunol. 2006 Nov 15;177(10):6930-9
17082608
Nat Immunol. 2004 Feb;5(2):224-9
14716311
Science. 2009 Aug 21;325(5943):1006-10
19608860
Blood. 2005 Feb 15;105(4):1777-84
15507530
Immunity. 2002 Aug;17(2):179-89
12196289
Oncogene. 2009 Aug 20;28(33):2925-39
19561645
J Biol Chem. 2000 Feb 4;275(5):3479-84
10652342
Oncogene. 2008 May 15;27(22):3111-21
18084330
Blood. 2009 May 28;113(22):5536-48
19307668
Nat Immunol. 2004 Mar;5(3):317-27
14758357
Immunity. 2001 Sep;15(3):375-85
11567628
Science. 2009 Aug 21;325(5943):1001-5
19628815
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3304-9
16492737
J Pathol. 1998 Jun;185(2):159-66
9713342
Nat Immunol. 2009 Oct;10(10):1110-7
19734904
Nat Immunol. 2006 May;7(5):489-97
16582912
Genes Dev. 1999 Jun 15;13(12):1501-12
10385618
Int J Cancer. 1999 May 17;81(4):543-50
10225442
Annu Rev Immunol. 2008;26:481-511
18304001
Blood. 1995 Jul 1;86(1):45-53
7795255
J Clin Invest. 2003 Feb;111(4):529-37
12588891
Cancer Cell. 2003 Dec;4(6):451-61
14706337
Mol Cell Biol. 2008 Apr;28(7):2175-86
18212045
J Exp Med. 1996 May 1;183(5):2303-12
8642339
Immunity. 2000 Aug;13(2):199-212
10981963
Blood. 2001 Nov 1;98(9):2837-44
11675358
Nat Rev Immunol. 2008 Jan;8(1):22-33
18097447
Immunity. 2007 Aug;27(2):190-202
17723214
Immunity. 2009 Sep 18;31(3):457-68
19631565
Cell. 2003 Aug 8;114(3):323-34
12914697
Immunity. 2002 Oct;17(4):501-14
12387743
J Exp Med. 1998 Mar 16;187(6):885-95
9500791
Immunity. 2005 Jun;22(6):749-61
15963789
J Exp Med. 2007 Dec 24;204(13):3095-101
18039950
Science. 1997 Apr 25;276(5312):589-92
9110977
Cell Cycle. 2005 Mar;4(3):388-91
15738651
Cell. 2004 Aug 20;118(4):477-91
15315760
Cell Cycle. 2008 Jul 15;7(14):2215-24
18635970
Annu Rev Immunol. 2008;26:261-92
18370922
J Immunol. 2006 Jul 15;177(2):787-95
16818732
Clin Cancer Res. 2002 Mar;8(3):729-33
11895902
Nature. 2004 Nov 18;432(7015):298-306
15549091
J Immunol. 2006 Oct 1;177(7):4341-9
16982868
J Exp Med. 2009 Aug 31;206(9):2013-25
19703988
Immunity. 2005 Sep;23(3):297-308
16169502
Nat Genet. 1997 Jun;16(2):161-70
9171827